A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer

NCT02402036 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Regorafenib

Sponsor

Georgetown University

Collaborators

[object Object]